197 related articles for article (PubMed ID: 23916409)
1. Cannabis abuse in adolescence and the risk of psychosis: a brief review of the preclinical evidence.
Rubino T; Parolaro D
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jul; 52():41-4. PubMed ID: 23916409
[TBL] [Abstract][Full Text] [Related]
2. [Adolescent cannabis consumption and schizophrenia: epidemiological and experimental evidences].
Parolaro D
Adicciones; 2010; 22(3):185-9. PubMed ID: 20802980
[TBL] [Abstract][Full Text] [Related]
3. Adolescent exposure to cannabis as a risk factor for psychiatric disorders.
Rubino T; Zamberletti E; Parolaro D
J Psychopharmacol; 2012 Jan; 26(1):177-88. PubMed ID: 21768160
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids and psychosis.
Sewell RA; Ranganathan M; D'Souza DC
Int Rev Psychiatry; 2009 Apr; 21(2):152-62. PubMed ID: 19367509
[TBL] [Abstract][Full Text] [Related]
5. [Behavioral, cognitive and psychophysiological effects of cannabinoids: relevance to psychosis and schizophrenia].
Sewell RA; Skosnik PD; Garcia-Sosa I; Ranganathan M; D'Souza DC
Braz J Psychiatry; 2010 May; 32 Suppl 1():S15-30. PubMed ID: 20512267
[TBL] [Abstract][Full Text] [Related]
6. Long lasting consequences of cannabis exposure in adolescence.
Rubino T; Parolaro D
Mol Cell Endocrinol; 2008 Apr; 286(1-2 Suppl 1):S108-13. PubMed ID: 18358595
[TBL] [Abstract][Full Text] [Related]
7. Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids.
Realini N; Rubino T; Parolaro D
Pharmacol Res; 2009 Aug; 60(2):132-8. PubMed ID: 19559364
[TBL] [Abstract][Full Text] [Related]
8. Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia.
Bossong MG; Niesink RJ
Prog Neurobiol; 2010 Nov; 92(3):370-85. PubMed ID: 20624444
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Exposure to Cannabinoids in Adolescence: Insights From Animal Models.
Rubino T; Parolaro D
Biol Psychiatry; 2016 Apr; 79(7):578-85. PubMed ID: 26344755
[TBL] [Abstract][Full Text] [Related]
10. [A review about cannabis use like as risk factor of schizophrenia].
Arias Horcajadas F
Adicciones; 2007; 19(2):191-203. PubMed ID: 17691420
[TBL] [Abstract][Full Text] [Related]
11. [Cannabis and psychosis--a review].
Schaub M; Rössler W; Stohler R
Praxis (Bern 1994); 2004 Jun; 93(23):997-1002. PubMed ID: 15233568
[TBL] [Abstract][Full Text] [Related]
12. Cannabis use in young people: the risk for schizophrenia.
Casadio P; Fernandes C; Murray RM; Di Forti M
Neurosci Biobehav Rev; 2011 Aug; 35(8):1779-87. PubMed ID: 21530584
[TBL] [Abstract][Full Text] [Related]
13. Cannabis use and psychotic disorders: an update.
Hall W; Degenhardt L; Teesson M
Drug Alcohol Rev; 2004 Dec; 23(4):433-43. PubMed ID: 15763748
[TBL] [Abstract][Full Text] [Related]
14. Cannabis and psychosis/schizophrenia: human studies.
D'Souza DC; Sewell RA; Ranganathan M
Eur Arch Psychiatry Clin Neurosci; 2009 Oct; 259(7):413-31. PubMed ID: 19609589
[TBL] [Abstract][Full Text] [Related]
15. What Can Rats Tell Us about Adolescent Cannabis Exposure? Insights from Preclinical Research.
Renard J; Rushlow WJ; Laviolette SR
Can J Psychiatry; 2016 Jun; 61(6):328-34. PubMed ID: 27254841
[TBL] [Abstract][Full Text] [Related]
16. Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats.
Zamberletti E; Beggiato S; Steardo L; Prini P; Antonelli T; Ferraro L; Rubino T; Parolaro D
Neurobiol Dis; 2014 Mar; 63():35-47. PubMed ID: 24200867
[TBL] [Abstract][Full Text] [Related]
17. Predictors of schizophrenia--a review.
Mäki P; Veijola J; Jones PB; Murray GK; Koponen H; Tienari P; Miettunen J; Tanskanen P; Wahlberg KE; Koskinen J; Lauronen E; Isohanni M
Br Med Bull; 2005; 73-74():1-15. PubMed ID: 15947217
[TBL] [Abstract][Full Text] [Related]
18. Pathways to psychosis in cannabis abuse.
Shrivastava A; Johnston M; Terpstra K; Bureau Y
Clin Schizophr Relat Psychoses; 2015 Apr; 9(1):30-5. PubMed ID: 23491968
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the Risks and Consequences of Adolescent Cannabis Exposure.
Levine A; Clemenza K; Rynn M; Lieberman J
J Am Acad Child Adolesc Psychiatry; 2017 Mar; 56(3):214-225. PubMed ID: 28219487
[TBL] [Abstract][Full Text] [Related]
20. Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort.
Manrique-Garcia E; Zammit S; Dalman C; Hemmingsson T; Andreasson S; Allebeck P
Psychol Med; 2012 Jun; 42(6):1321-8. PubMed ID: 21999906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
